Liz Stubbs
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liz Stubbs has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Amanda Jane Leach
Menzies School of Health Research, Charles Darwin University, Darwin, Australia
1 shared publication - Cate A Wilson
Menzies School of Health Research, John Mathews Building (Bldg58), Royal Darwin Hospital, Rocklands Drive, Tiwi, Northern Territory, Australia
1 shared publication - Gabrielle Britt McCallum
Child Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia
1 shared publication - Heidi C. Smith-Vaughan
Menzies School of Health Research Charles Darwin University Darwin Australia
1 shared publication - Jemima Beissbarth
Menzies School of Health Research, Charles Darwin University
1 shared publication - Kim M. Hare
Child Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia
1 shared publication
Latest Publications
- Open Access
- 4 August 2009
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1) , 121
Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
In Australia in June 2001, a unique pneumococcal vaccine schedule commenced for Indigenous infants; seven-valent pneumococcal conjugate vaccine (7PCV) given at 2, 4, and 6 months of age and 23-valent pneumococcal polysaccharide vaccine (23PPV) at 18 months of age. This study presents carriage serotypes following this schedule.
- 4 August 2009
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 9 (1) , 121
Open AccessEmerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001
In Australia in June 2001, a unique pneumococcal vaccine schedule commenced for Indigenous infants; seven-valent pneumococcal conjugate vaccine (7PCV) given at 2, 4, and 6 months of age and 23-valent pneumococcal polysaccharide vaccine (23PPV) at 18 months of age. This study presents carriage serotypes following this schedule.